DEF: U.S. Physical Therapy 2026 Proxy Statement Overview

U.S. Physical Therapy, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.

Summary

• The 2026 Annual Meeting of Stockholders is scheduled for May 19, 2026, in Houston, Texas.
• Key agenda items include the election of seven directors, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent auditor for 2026.
• The Board recommends voting FOR all director nominees, FOR the executive compensation proposal, and FOR the auditor ratification.
• The company reported 2025 Adjusted EBITDA of $95,010,000.
• CFO Carey P. Hendrickson resigned effective April 24, 2026, with Jason Curtis assuming responsibilities on an interim basis.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a stable and transparent governance filing, reflecting consistent operational performance and proactive alignment of executive compensation with shareholder interests, despite the transition in the CFO role.

Positives

• Strong financial performance in 2025 with Adjusted EBITDA reaching $95,010,000.
• Successful implementation of double-trigger change-in-control benefits for executive officers.
• Adoption of a formal Clawback Policy to recover incentive-based compensation in the event of financial restatements.
• Implementation of Officer and Director Share Ownership Guidelines to align leadership interests with shareholders.
• High level of shareholder support for executive compensation, with 91% approval at the 2025 Annual Meeting.

Negatives

• Resignation of the Chief Financial Officer, Carey P. Hendrickson, effective April 24, 2026.
• Two directors, Nancy J. Ham and Clayton K. Trier, are retiring and not standing for re-election.
• The company faces ongoing challenges in a competitive healthcare environment, including Medicare rate pressures.

Risks

• Potential for future changes in healthcare legislation and regulatory environments affecting reimbursement rates.
• Cybersecurity risks related to the protection of sensitive patient health information.
• Dependence on the ability to attract and retain qualified physical therapists and clinical staff.
• Risks associated with the integration of acquired businesses, such as the Metro MSO LLC acquisition.

Future Outlook

The company continues to focus on long-term value creation through de novo development, strategic acquisitions, and partnerships with hospital systems, while maintaining cost discipline and enhancing revenue cycle management.

Management Comments

• The Board believes that combining the roles of Chairman and CEO, alongside a strong Lead Independent Director, promotes the pursuit of business objectives and strategic growth.
• The company is committed to enhancing board diversity and has memorialized this commitment in its Board Diversity Policy.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy is navigating a consolidating outpatient rehabilitation market, balancing aggressive acquisition strategies with the need for operational efficiency and regulatory compliance in a post-pandemic healthcare landscape.

Comparison to Industry Standards

• The company benchmarks its executive compensation against a peer group including Surgery Partners, Inc., Astrana Health, Inc., and RadNet, Inc.
• The company's ESG reporting aligns with the Sustainability Accounting Standards Board (SASB) standards for the healthcare industry.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• The Audit Committee reviewed two real estate leases involving director Michael G. Mayrsohn, confirming terms were consistent with fair market value.

Stakeholder Impact

• Shareholders are requested to vote on key governance and compensation matters.
• Employees and partners are impacted by the ongoing focus on operational efficiency and compliance.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on May 19, 2026.
• Conduct a comprehensive search for a permanent successor to the Chief Financial Officer.
• Continue the integration of Metro MSO LLC and other recent acquisitions.

Key Dates

Recommendation

The filing is a standard annual proxy statement. While it confirms solid financial performance and good governance practices, it does not contain material news that would significantly shift the company's valuation or investment thesis.

Keywords

U.S. Physical Therapy, USPH, Proxy Statement, Executive Compensation, Corporate Governance, Healthcare Services, Physical Therapy, Annual Meeting